Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis

[51] Hennige AM(2013)Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study Diabetes Care 36 3121-4723

[52] Staiger H(2009)NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study Am J Gastroenterol 104 861-2340

[53] Wicke C(2014)Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease N Engl J Med 371 2236-433

[54] Stefan N(2011)The metabolically benign and malignant fatty liver Diabetes 60 2011-2930

[55] Hennige AM(2013)The role of hepatokines in metabolism Nat Rev Endocrinol 9 144-undefined

[56] Staiger H(2012)Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose J Clin Endocrinol Metabol 97 4717-undefined

[57] Mori K(2003)Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study Diabetes Care 26 2335-undefined

[58] Emoto M(1999)Relationships of fasting and postload glucose levels to sex and alcohol consumption. Are American Diabetes Association criteria biased against detection of diabetes in women? Diabetes Care 22 430-undefined

[59] Yokoyama H(2005)Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification J Am Soc Nephrol JASN 16 2920-undefined

[60] Kahn SE(undefined)undefined undefined undefined undefined-undefined

[51] Hennige AM(2013)Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study Diabetes Care 36 3121-4723

[52] Staiger H(2009)NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study Am J Gastroenterol 104 861-2340

[53] Wicke C(2014)Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease N Engl J Med 371 2236-433

[54] Stefan N(2011)The metabolically benign and malignant fatty liver Diabetes 60 2011-2930

[55] Hennige AM(2013)The role of hepatokines in metabolism Nat Rev Endocrinol 9 144-undefined

[56] Staiger H(2012)Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose J Clin Endocrinol Metabol 97 4717-undefined

[57] Mori K(2003)Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study Diabetes Care 26 2335-undefined

[58] Emoto M(1999)Relationships of fasting and postload glucose levels to sex and alcohol consumption. Are American Diabetes Association criteria biased against detection of diabetes in women? Diabetes Care 22 430-undefined

[59] Yokoyama H(2005)Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification J Am Soc Nephrol JASN 16 2920-undefined

[60] Kahn SE(undefined)undefined undefined undefined undefined-undefined